FRANCESCO DEMAYO to In Situ Nick-End Labeling
This is a "connection" page, showing publications FRANCESCO DEMAYO has written about In Situ Nick-End Labeling.
Connection Strength
0.069
-
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
Score: 0.024
-
Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol. 2012 Sep; 26(9):1552-66.
Score: 0.024
-
Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 2000 Jun 15; 14(12):1448-59.
Score: 0.010
-
Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2000 Mar; 32(3):365-74.
Score: 0.010